Weiss Multi-Strategy Advisers LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q2 2019$161,000
-42.5%
40,000
-38.5%
0.00%
-42.9%
Q1 2019$280,000
-25.1%
65,0000.0%0.01%
-56.2%
Q4 2018$374,000
-60.6%
65,000
-7.1%
0.02%
-36.0%
Q3 2018$949,000
-0.1%
70,000
-12.5%
0.02%
+8.7%
Q2 2018$950,000
+5.8%
80,0000.0%0.02%
-17.9%
Q1 2018$898,000
+34.4%
80,000
-20.0%
0.03%
+64.7%
Q4 2017$668,000
-19.2%
100,000
-1.0%
0.02%
-45.2%
Q3 2017$827,000
+82.6%
101,0000.0%0.03%
+63.2%
Q2 2017$453,000
-25.2%
101,000
-8.2%
0.02%
-20.8%
Q1 2017$606,000
+35.9%
110,0000.0%0.02%
+9.1%
Q4 2016$446,000
-1.1%
110,000
+71.9%
0.02%
-21.4%
Q3 2016$451,000
-15.7%
64,000
-2.5%
0.03%
-31.7%
Q2 2016$535,000
-40.2%
65,610
-40.4%
0.04%
+5.1%
Q1 2016$894,000
-28.0%
110,000
+6.8%
0.04%
-54.7%
Q4 2015$1,242,000
-11.3%
103,000
-12.0%
0.09%
+38.7%
Q3 2015$1,400,000
-36.4%
117,000
-2.5%
0.06%
-28.7%
Q2 2015$2,200,000120,0000.09%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$2,341,0003.33%
Matrix Capital Management Company, LP 38,974,185$66,256,0001.50%
NEA Management Company, LLC 17,082,612$29,040,0001.49%
Endurant Capital Management LP 1,824,065$3,101,0001.09%
Long Focus Capital Management, LLC 4,679,491$7,955,0000.83%
Key Client Fiduciary Advisors, LLC 416,166$707,0000.69%
PFM Health Sciences, LP 9,109,780$15,487,0000.59%
ACT CAPITAL MANAGEMENT, LLC 90,000$153,0000.21%
DAFNA Capital Management LLC 351,064$597,0000.16%
Rock Springs Capital Management LP 2,357,544$4,008,0000.12%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders